021-51111890
购物车（）
sales@molnova.cn
Lobaplatin (D-19466)
CAS No. 135558-11-1
Lobaplatin (D-19466) ( D-19466 )
产品货号. M21767 CAS No. 135558-11-1
Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes. Lobaplatin (D-19466) shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2252 | 有现货 |
|
| 10MG | ￥3710 | 有现货 |
|
| 25MG | ￥6099 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lobaplatin (D-19466)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes. Lobaplatin (D-19466) shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent.
-
产品描述Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes. Lobaplatin (D-19466) shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent.
-
同义词D-19466
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number135558-11-1
-
分子量397.33
-
分子式C9H18N2O3Pt
-
纯度>98% (HPLC)
-
溶解度H2O : ≥ 50 mg/mL (125.84 mM; DMSO can inactivate Lobaplatin's activity)
-
SMILESCC1[O-][Pt+2]2([NH2]CC3C(CC3)C[NH2]2)[O-]C1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Cao H, et al. Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX. Dose Response. 2019 Jun 5;17(2):1559325819850981.
2. McKeage MJ, et al. Lobaplatin: a new antitumour platinum drug. Expert Opin Investig Drugs. 2001 Jan;10(1):119-28.
产品手册
关联产品
-
Boldenone
Boldenone is an anabolic steroid developed for veterinary use.
-
Sakamototide substra...
Sakamototide substrate peptide TFA is a peptide substrate of AMPK kinase family and can be used for the determination of kinase activity.
-
Dehydromiltirone
Dehydromiltirone has antioxidant activity, it shows significant anti-neuroinflammatory effects through inhibiting PI3K/Akt phosphorylation and then inhibiting NF-κB signaling pathway.
